
Boxlight Launches CL Totem in North America, Providing Modern, Freestanding Digital Signage Built for High-Traffic Environments
Available in 49" and 55", the CL Totem brings together bold visuals, modern design and effortless content management in one self-contained, freestanding unit. Built for high-traffic environments like retail stores, hotel lobbies, restaurants and corporate campuses, the CL Totem delivers high-impact messaging—without the complexity of traditional signage systems.
'What makes the CL Totem so exciting is that it delivers the kind of polished, high-impact signage experience that organizations have been asking for—without the setup headaches or recurring costs,' said Daniel Morris, Boxlight's Category Manager – Displays (Americas) and Director of Enterprise & Government Sales. 'It's a sleek, professional display that works right out of the box, with the flexibility to adapt to retail, hospitality or public spaces.'
Unique features of the CL Totem:
This launch marks another step in Boxlight's strategy to unify its digital signage and interactive display offerings under a common platform, giving customers a streamlined, scalable visual communication solution.
The CL Totem is now available. To learn more, visit boxlight.com.
®, FrontRow™ and Mimio ®. The Company aims to improve engagement and communication in diverse business and education environments. Boxlight develops, sells and services its integrated solution suite including interactive displays, collaboration software, audio solutions, supporting accessories, and professional services. For more information about Boxlight and the Boxlight story, visit http://www.boxlight.com and http://www.clevertouch.com and https://www.gofrontrow.com.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
Could Buying Remitly Global Stock Today Set You Up for Life?
Remitly is growing quickly but facing a lot of potential threats over news around stablecoins and remittance taxes. The company can work through any disruptions in the remittance market and has a superior value proposition to the competition. Shares of the stock look cheap after declining by a third. 10 stocks we like better than Remitly Global › The stock market keeps soaring, but Remitly Global (NASDAQ: RELY) has failed to join the party. Shares of the mobile remittance platform have tumbled 33% from highs set earlier this year due to perceived risks over reduced immigration to the U.S., potential taxes on remittances, and the rise of stablecoins for international money transfers. There is a lot of negativity over Remitly Global stock right now. I believe these doubts are overblown. Here's why buying Remitly stock could set your portfolio up for life. Compared to traditional remittances, Remitly Global is vastly superior for almost any customer looking to send money from one country to another. Remitly has an easy-to-use mobile application and lower fees than traditional players like Western Union. It is able to do so because it does not operate any physical money transfer centers, but it still partners with physical receiving locations in foreign countries when that is the preferred option for the person receiving money. Due to this growing competitive advantage, Remitly's send volume is growing at the fastest pace in the industry. Last quarter, send volume was up 41% year over year to $16.2 billion. And yet, it still holds only a small sliver of the global international money transfer market. It is investing heavily in new products such as a WhatsApp integration and tools for microbusinesses, while also expanding into new corridors outside of its original key markets sending from the U.S. to India, the Philippines, and Mexico. All this has led Remitly's revenue to grow at a phenomenal rate during the past few years. Since 2019, revenue has compounded at a 57% annual rate, growing from $126 million to $1.36 billion. It can be confusing to see Remitly growing so rapidly while simultaneously seeing its stock price fall. This is because of two huge narratives that are striking fear into investors. First is all the hype around stablecoins. Stablecoins are cryptocurrencies tied to a fiat currency, typically the U.S. dollar. In theory, it should be cheaper to send money digitally through stablecoins, bypassing traditional systems. There has been plenty of regulation around stablecoins in the U.S. as industry bulls try to get product adoption. However, using stablecoins to transfer money runs into an issue, which is converting said stablecoin into a currency your receiver can actually use in real life. At this step, you will still pay the same fee as before, just with an extra step. I have no doubt, either, that Remitly can begin to accept stablecoins as a form of funds once it gets regulatory approval. This is not a huge risk for the business. Second, Remitly is facing potential pressure due to immigrant deportations, which could present a small headwind to the business. There is also a proposed tax on remittances. A changing immigration landscape may hurt Remitly's growth ever so slightly, but this tax is nothing to be worried about. It is only 1% and a tax on cash payments only. As it stands, the tax should help Remitly gain a competitive edge over traditional money transfer methods. RELY Revenue (TTM) data by YCharts After the sharp share price decline, I believe Remitly stock is cheap and a perfect set-up for investors looking to buy and hold over the next 10 years. It has only 2% to 3% of the remittance market, giving it a ton of room to take share in a sector that has grown with globalization of work. Today, the company has a market cap of $3.8 billion. It generated $1.36 billion in revenue during the past 12 months and it expects to generate more than $1.5 billion in revenue this year. The business has strong unit economics due to its digital-first strategy, with 60% gross profit margins that have ticked higher year after year. These wide margins should convert to 20% or higher bottom-line profit margins at scale, although today the company isn't generating much in profit because of its heavy spending on product development and marketing. Remitly's $1.5 billion in revenue at a 20% profit margin equals $300 million in earnings, or a theoretical price-to-earnings ratio (P/E) of just 12. In five or 10 years, Remitly's revenue will be much higher than $1.5 billion, too, which should drive the stock price higher. Remitly stock looks like a multibagger in the making; investors could likely buy and watch the returns roll in during the next decade. Before you buy stock in Remitly Global, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Remitly Global wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $699,558!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $976,677!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Brett Schafer has positions in Remitly Global. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Could Buying Remitly Global Stock Today Set You Up for Life? was originally published by The Motley Fool

Miami Herald
2 hours ago
- Miami Herald
Watch out for the threats that could derail the big rally
After a rally for the ages, the week ahead presents investors with some risks, maybe some big risks if people aren't careful. There are a few earnings reports to watch out for. Delta Air Lines (DAL) , due Thursday, started warning about bookings in March. Still, the second-quarter earnings season doesn't really kick in for real for another week. Don't miss the move: Subscribe to TheStreet's free daily newsletter Which leaves investors, whether professional managing billions or small investors trying to build a retirement stake, left to their own devices. So here's how the next week sets up. The big rally since roughly April 7 has made more money for stocks overall in two months than they did in all of 2024. The S&P 500 finished the week at 6,275. The close was a record, and the index hit a 52-week high of 6,285. The Nasdaq Composite also closed at a record 20,601, and it set a 52-week high of 20,624. The Nasdaq-100's close was a record 22,867 and reached as high as 22,896 on Friday. Related: Fund manager panel raises eyebrows with market forecasts The Dow Jones Industrial Average closed Friday at 44,829, its best finish in 2025. It's just 0.5% below its 52-week high of 45,074, reached in December. The small-cap Russell 2000 average ended Friday at 2,249, up 1%, but has struggled to keep pace with its brethren. Here's how the numbers work: S&P 500, up 29.9% since its 52-week low on April Nasdaq Composite: up 39.4% since April Nasdaq-100: up 38,2% from April Dow: up 22.4% from April Russell 2000: up 29.8% from April 9 low. But there is a catch: The weak first quarter performance and then the market reaction to President Trump's Liberation Plan on tariffs nearly offset the gains since April. Here's where the indexes stand for the year: S&P 500 is up just 6.8%. The Nasdaq: up 6.7%.The Nasdaq-100: up 8.8%.The Dow: up 5.4%. The Russell 2000: up 0.9%. Related: Goldman Sachs revamps Fed interest rate cut forecast for 2025 The big rally has many people on Wall Street very excited. Not just because it's so big but because it's what they all dreamed about after Donald Trump won the White House last November. Stocks would soar, they argued, because: Taxes would be cut. The big beautiful bill has been passed and signed. Regulation would be loosened. The administration, for better or worse, is doing just spirits, Wall Street's favorite catch phrase, would be set free. Here are the risks the markets face. President Trump wanted all trade negotiations with some 90 countries to be done signed by July 9. If a deal isn't done, the administration will send out letters as early as Monday saying in effect, "Here's what your tariff will be starting Aug. 1." From, maybe, 25% or so on European motor vehicles to 70%. The question is if the Administration will impose the tariffs as suddenly and crazily, as Trump threatened in April. More Economic Analysis: 'Wrong Way' Economic Bears Drive the S&P 500 to Another All-Time HighFederal Reserve prepares strong message on long-term interest ratesWeekly Wins: A Win for WYNN Resorts from Helene MeislerAnalyst makes bold call on stocks, bonds, andThursday's jobs report looked bullish on the surface, and a number of Wall Street firms started to boost their S&P 500 price targets. When 2025 opened, 7,000 on the index was the upper end again. Many analysts chopped forecasts back in April. But looking deeply into the jobs report suggests that private-sector employment was largely flat from May to June. The gains the Labor Department reported were concentrated mostly in government and non-profit sectors. Meanwhile, tech companies are laying off thousands. Microsoft (MSFT) announced 9,000 job cuts just this past week. And the future? We'll let Ford (F) CEO Jim Farley's recent prediction do the talking: "Artificial intelligence is going to replace literally half of all white-collar workers in the U.S." he told biographer Walter Isaacson at the Aspen Ideas Festival last month. Is anyone ready for that? Related: Analyst resets Datadog stock price target after surprise addition to S&P 500 President Trump's promise his policies will generate much more oil drilling in the United States assumes oil prices will remain. A warning: OPEC+, the group that follows production policies of when the Organization of Petroleum Exporting Countries, agreed Saturday to raise production by 548,000 barrels per day in August. The move further accelerated output increases at the group's first meeting since oil prices jumped - and then retreated - following Israeli and U.S. attacks on Iran in June. West Texas intermediate, the benchmark U.S. crude, finished Thursday at $67 a barrel. It's down 7.3% this year. Baker Hughes oil-rig data shows 539 rigs operating in the United States as of July 3, down 8% from a year ago. Relative strength indexes for all the indexes we've discussed ended Friday above 70, a signal prices are getting frothy. The indexes themselves may not be badly overbought: You need an RSI of 80 more to make the case. Even then, the animal spirits might not give up the game. But, when Thursday ended, 87 S&P 500 stocks had RSIs above 70. (U.S. markets were closed Friday for July 4.) Of these, 15 showed RSI levels above 80. Tops is Jabil Inc. (JBL) at 89. Others include financial giants Goldman Sachs (GS) , Citigroup (C) , State Street (STT) . JP Morgan Chase (JPM) , Morgan Stanley (MS) . Bank of America's (BAC) RSI is at 79. Again, high RSI levels don't mean stocks are ready to tumble. But a mistake - in the economy, in politics, in the markets - will make it easy for the risk-averse to commence some selling. We wlll probably see some this summer. Futures trading late Friday showed indexes falling. Sunday's late trading will offer a clearer picture. Related: Legendary fund manager issues stock market prediction as S&P 500 tests all-time highs The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Yahoo
3 hours ago
- Yahoo
Morgan Stanley Lifts PT on CG Oncology (CGON) to $56, Keeps an Overweight Rating
CG Oncology, Inc. (NASDAQ:CGON) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On June 17, Morgan Stanley raised the firm's price target on CG Oncology, Inc. (NASDAQ:CGON) to $56 from $52, while maintaining an Overweight rating on the shares. A researcher in a laboratory examining a vial of oncolytic herpes simplex virus, demonstrating the company's commitment to finding a cure for cancer. The firm told investors in a research note that although the non-muscle invasive bladder cancer space has undergone recent and anticipated approvals, the space is comprehensive enough to accommodate multiple players. It thus considers cretostimogene to be meaningfully differentiated by its safety data and durability, along with having 'best-in-disease potential' that supports an optimistic rating for the company. CG Oncology, Inc. (NASDAQ:CGON) is a clinical biopharmaceutical company that develops and commercializes bladder-sparing therapeutics for bladder cancer. Its product cretostimogene is initially in clinical development for the treatment of Non-Muscle Invasive Bladder Cancer (NMIBC). While we acknowledge the potential of CGON as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.